Nasdaq:GOCO
GoHealth, Inc.
A digital-first healthcare aggregator leveraging technology to lower costs for consumers while expanding access to primary care and diagnostics across the US market.
Key Metrics
Investment Thesis
Bull Case
Investors may favor GOCO due to its clear path to profitability evidenced by shrinking losses over the last three years and robust revenue growth from $631.7M in 2022 to nearly $800M in 2024. The company's dual model of online referrals and physical centers creates a scalable flywheel effect that competitors struggle to replicate without similar heavy investments.
Bear Case
The stock faces headwinds from persistent operating losses and a negative cash flow from operations, which could limit flexibility during economic downturns or funding tightening. Additionally, the company carries substantial long-term debt of $447.9M, creating refinancing risk if interest rates remain elevated or credit conditions deteriorate.
About GoHealth, Inc.
GoHealth, Inc. (GOCO) is a leading healthcare technology company operating primarily in the United States, specializing in connecting patients with affordable medical services through its GoHealth Online platform and direct patient care centers.
Analysis
Management Discussion
GoHealth demonstrated significant operational improvement in 2024, narrowing its net loss to $7.3M from a deficit of $151.3M in 2023 and $376.4M in 2022, while revenue grew to $798.9M. Despite a negative cash flow from operations of $21.6M, the company maintained a strong balance sheet with $40.9M in cash and equivalents against total assets of $1.49B, indicating a trajectory toward profitability as its direct care model matures.
Industry Overview
The digital healthcare industry is experiencing rapid consolidation as consumers demand convenience and transparency, driving growth for aggregators that blend telehealth with in-person care. Regulatory environments remain fragmented across US states, presenting both barriers to entry for new players and opportunities for established firms with compliance expertise.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $631.7M | $734.7M | $798.9M |
| Cost of Revenue | $187.7M | $159.0M | $130.6M |
| Gross Profit | $444.0M | $575.7M | $668.3M |
| Operating Expenses | $762.7M | $657.4M | $675.3M |
| Operating Income | $-318.7M | $-81.7M | $-7.0M |
| G&A | $116.5M | $93.1M | $82.1M |
| Stock-Based Comp | $27.1M | $19.5M | $11.3M |
| D&A | $12.9M | $11.7M | $11.8M |
| Depreciation | $6.4M | $3.9M | $3.7M |
| Amortization | $94.1M | $94.1M | $94.1M |
| Other OpEx | $646.1M | $564.3M | $593.2M |
| Non-Operating Income | $-57.0M | $-69.4M | $2.0M |
| Interest Expense | $57.1M | $69.5M | — |
| Pre-Tax Income | $-375.6M | $-151.1M | $-5.1M |
| Income Tax | $764.0K | $154.0K | $2.3M |
| Continuing Ops | $-376.4M | $-151.3M | $-7.3M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-376.4M | $-151.3M | $-7.3M |
| Minority Interest | $-227.7M | $-88.0M | $-4.4M |
| Net to Common | $-148.7M | $-63.3M | $-2.9M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $414.6M | $476.4M | $400.4M |
| Cash & Equivalents | $16.5M | $90.8M | $40.9M |
| Accounts Receivable | $4.7M | $250.0K | $4.5M |
| Prepaid Expenses | $57.6M | $49.2M | $34.6M |
| Other Current Assets | $335.8M | $336.2M | $320.4M |
| Long-Term Assets | $1.24B | $1.02B | $1.09B |
| Intangibles | $500.6M | $396.6M | $302.5M |
| Operating Leases | $21.5M | $22.0M | $19.3M |
| Other LT Assets | $722.6M | $604.6M | $766.2M |
| Total Assets | $1.66B | $1.50B | $1.49B |
| Current Liabilities | $265.5M | $370.0M | $338.1M |
| Accounts Payable | $15.1M | $17.7M | $14.6M |
| Current Debt | $5.3M | $75.0M | $39.5M |
| Current Leases | $9.0M | $5.8M | $5.7M |
| Other Current Liab | $182.7M | $185.3M | $156.9M |
| Long-Term Liabilities | $851.4M | $723.9M | $744.9M |
| Long-Term Debt | $504.8M | $422.7M | $447.9M |
| LT Operating Leases | $38.4M | $39.5M | $34.9M |
| Other LT Liab | $308.3M | $261.7M | $262.2M |
| Total Liabilities | $1.12B | $1.09B | $1.08B |
| Shareholders' Equity | $542.4M | $405.7M | $405.4M |
| Paid-In Capital | $626.3M | $654.1M | $669.3M |
| Retained Earnings | $-357.0M | $-420.3M | $-423.2M |
| AOCI | $-144.0K | $-127.0K | $-151.0K |
| Total L&E | $1.66B | $1.50B | $1.49B |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-376.4M | $-151.3M | $-7.3M |
| Non-Cash Adjustments | $705.7M | $358.2M | $-65.3M |
| Working Capital Changes | $-268.5M | $-97.7M | $51.0M |
| Cash from Operations | $60.9M | $109.1M | $-21.6M |
| Cash from Investing | $-13.5M | $-13.7M | $3.8M |
| Cash from Financing | $-115.1M | $-21.1M | $-32.0M |
| FX Effect | $-238.0K | $42.0K | $-55.0K |
| Net Change in Cash | $-67.9M | $74.3M | $-49.9M |
| Beginning Cash | $84.4M | $16.5M | $90.8M |
| Ending Cash | $16.5M | $90.8M | $40.9M |
Frequently Asked Questions
How does GoHealth, Inc. make money?
The company derives revenue primarily from three core segments: 1) GoHealth Online, a referral marketplace connecting patients with providers; 2) Direct Patient Care Centers offering primary care, urgent care, and diagnostic services; and 3) Ancillary services including imaging, lab testing, and specialty referrals that support the broader patient journey.
What are the main risks for GOCO?
1) Regulatory headwinds from state-level laws restricting out-of-network reimbursement or limiting telehealth parity; 2) Intense competition from established insurance carriers launching digital-first initiatives and independent telehealth players; 3) High capital expenditure requirements for expanding physical care center footprint and technology infrastructure; 4) Sensitivity to macroeconomic downturns affecting discretionary consumer spending on healthcare services.
What is GOCO's competitive advantage?
1) First-mover advantage in aggregating diverse healthcare services under a single digital ecosystem; 2) Proprietary technology stack enabling seamless integration of online consultations with physical care delivery; 3) Significant scale allowing for negotiated favorable rates with providers and suppliers, improving margins as volume grows.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.